Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
FCN-098
i
Other names:
FCN-098
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Fosun Pharma
Drug class:
Trk inhibitor
Related drugs:
‹
repotrectinib (27)
SIM1803-1A (5)
K-252a (1)
OPN-7486 (1)
BAY 2731954 (1)
AGX87 (0)
ONO-7579 (0)
TL118 (0)
TY-2136b (0)
XZP-5955 (0)
TSR-011 (0)
repotrectinib (27)
SIM1803-1A (5)
K-252a (1)
OPN-7486 (1)
BAY 2731954 (1)
AGX87 (0)
ONO-7579 (0)
TL118 (0)
TY-2136b (0)
XZP-5955 (0)
TSR-011 (0)
›
Associations
(3)
News
Trials
Filter by
Latest
almost3years
Study of FCN-098 in Patients With Advanced Solid Tumor (clinicaltrials.gov)
P1, N=43, Recruiting, Fochon Pharmaceuticals, Ltd.
almost 3 years ago
New P1 trial
|
NTRK (Neurotrophic receptor tyrosine kinase)
|
NTRK positive • NTRK fusion
|
FCN-098
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login